Redwood Grove Capital’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-81,557
Closed -$3.93M 27
2026
Q1
$3.93M Sell
81,557
-107,284
-57% -$5M 1.27% 20
2025
Q4
$9.15M Sell
188,841
-64,000
-25% -$3.17M 2.61% 20
2025
Q3
$11.9M Sell
252,841
-32,000
-11% -$1.54M 3.42% 16
2025
Q2
$13.8M Hold
284,841
4.57% 11
2025
Q1
$15.8M Sell
284,841
-71,600
-20% -$3.88M 5.66% 6
2024
Q4
$17.2M Hold
356,441
5.32% 4
2024
Q3
$20.5M Buy
356,441
+80,537
+29% +$4.35M 5.58% 5
2024
Q2
$13.4M Buy
275,904
+14,750
+6% +$712K 4.19% 12
2024
Q1
$12.7M Buy
261,154
+21,710
+9% +$1.06M 3.95% 14
2023
Q4
$11.9M Buy
239,444
+76,900
+47% +$3.76M 4.4% 9
2023
Q3
$8.72M Buy
162,544
+16,000
+11% +$853K 3.49% 16
2023
Q2
$7.9M Hold
146,544
3.34% 17
2023
Q1
$7.97M Hold
146,544
3.8% 16
2022
Q4
$7.1M Hold
146,544
3.52% 16
2022
Q3
$5.57M Buy
146,544
+96,300
+192% +$4.29M 3.06% 18
2022
Q2
$2.51M Hold
50,244
1.37% 23
2022
Q1
$2.62M Hold
50,244
1.3% 23
2021
Q4
$2.52M Buy
50,244
+4,000
+9% +$198K 1.18% 22
2021
Q3
$2.23M Hold
46,244
1.27% 21
2021
Q2
$2.44M Buy
46,244
+10,000
+28% +$522K 1.31% 22
2021
Q1
$1.79M Hold
36,244
1.1% 23
2020
Q4
$1.76M Buy
+36,244
New +$1.79M 1.28% 21

Other funds holding SNY

Redwood Grove Capital's SNY Position: Q2 2026 in Review

Redwood Grove Capital sold out of Sanofi (SNY) in Q2 2026, closing a stake of 81,557 shares — an estimated $3.93M sold.

Redwood Grove Capital first reported a position in SNY in Q4 2020 and held it in 22 quarters. The position peaked at $20.5M in Q3 2024. 717 funds tracked by Wall St. Rank hold SNY as of Q2 2026.

  • Redwood Grove Capital reported no remaining Sanofi position as of Q2 2026 after selling out during the quarter.
  • Redwood Grove Capital sold 81,557 Sanofi shares in Q2 2026, an estimated $3.93M.
  • Redwood Grove Capital first reported a position in Sanofi in Q4 2020 and held it in 22 quarters.
  • Redwood Grove Capital's Sanofi position peaked at $20.5M in Q3 2024.
  • 717 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.

Based on Redwood Grove Capital's 13F filing for Q2 2026, filed 14 Aug 2026.